Integrase Strand Transfer Inhibitors (instis) - Infectious Diseases

Relevant Publications

Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China.

Issue Release: 2024

Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV.

Issue Release: 2024

\"Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons with HIV Differs by Sex\".

Issue Release: 2024

Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions.

Issue Release: 2024

Comprehensive Database of HIV Mutations Selected During Antiretroviral In Vitro Passage Experiments.

Issue Release: 2024

Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.

Issue Release: 2024

Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.

Issue Release: 2024

Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV.

Issue Release: 2024

Full-Spectrum Surveillance of Pre-Treatment HIV Drug Resistance in Southeastern China.

Issue Release: 2024

HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola.

Issue Release: 2024

Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.

Issue Release: 2024

Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature.

Issue Release: 2024

Elucidating the Molecular Determinants of the Binding Modes of a Third-Generation HIV-1 Integrase Strand Transfer Inhibitor: The Importance of Side Chain and Solvent Reorganization.

Issue Release: 2024

Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention.

Issue Release: 2024

Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.

Issue Release: 2024

Molecular design and evaluation of aza-polycyclic carbamoyl pyridones as HIV-1 integrase strand transfer inhibitors.

Issue Release: 2024

Increased incidence of diabetes in people living with HIV treated with first-line integrase strand transfer inhibitors: A French multicentre retrospective study.

Issue Release: 2024

Epidemic trend, genetic characteristics, and transmission networks of HIV-1 among treatment-naive men who have sex with men in Hebei province, China.

Issue Release: 2024

Antiretroviral drug dolutegravir induces inflammation at the mouse brain barriers.

Issue Release: 2024

Drug-drug interactions in hiv-infected patients receiving chemotherapy.

Issue Release: 2024

What is the Prognosis for Children with Microcephaly?

How is Rabies Transmitted?

Can Climate Change Affect Mosquito-Borne Diseases?

How Does NAT Work?

Are There Risks Associated with Imaging?

Who is eligible for Dengvaxia?

What are the benefits of using condoms beyond STI prevention?

What Treatments are Available for Bacterial Infections?

How Do Fungi Infect Hosts?

How do Viruses Cause Disease?

Integrase Strand Transfer Inhibitors (instis) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics